SEC Form 4 · accession 0000899243-15-004960
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curran Simpson
Officer — SVP of Technical Operations
Period of report
Sep 16, 2015
Accepted (ET)
Sep 17, 2015 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $22.00 | Sep 16, 2015 | A | 230,500 | A | — | Aug 30, 2025 | Common Stock | 230,500 | 230,500 | D |
Explanation of responses
- F1The option will vest over four years beginning on August 31, 2015. 25% of the shares will vest after the first year of service from August 31, 2015. The remaining 75% of the shares will vest in equal monthly installments over the next 36 months.